Regeneron finally captures an FDA OK with new eye drug - FierceBiotech

PHRhYmxlIGJvcmRlcj0iMCIgY2VsbHBhZGRpbmc9IjIiIGNlbGxzcGFjaW5nPSI3IiBzdHlsZT0i
dmVydGljYWwtYWxpZ246dG9wOyI PHRyPjx0ZCB3aWR0aD0iODAiIGFsaWduPSJjZW50ZXIiIHZh
bGlnbj0idG9wIj48Zm9udCBzdHlsZT0iZm9udC1zaXplOjg1JTtmb250LWZhbWlseTphcmlhbCxz
YW5zLXNlcmlmIj48YSBocmVmPSJodHRwOi8vbmV3cy5nb29nbGUuY29tL25ld3MvdXJsP3NhPXQm
YW1wO2ZkPVImYW1wO3VzZz1BRlFqQ05IcjZJS0ttYW5OM0V5cS0tT3djNV9IMUJxM2h3JmFtcDt1
cmw9aHR0cDovL3d3dy5tZWRpbmRpYS5uZXQvbmV3cy9GREEtQXBwcm92ZXMtTmV3LURydWctRXls
ZWEtZm9yLUJsaW5kbmVzcy05MzY1OC0xLmh0bSI PGltZyBzcmM9Imh0dHA6Ly9udDIuZ2dwaHQu
Y29tL25ld3MvdGJuLy11dlNNa1JNM1hxeGJNLzYuanBnIiBhbHQ9IiIgYm9yZGVyPSIxIiB3aWR0
aD0iODAiIGhlaWdodD0iODAiIC8 PGZvbnQgc2l6ZT0iLTIiPk1lZEluZGlhPC9mb250PjwvYT48
L2ZvbnQ PC90ZD48dGQgdmFsaWduPSJ0b3AiIGNsYXNzPSJqIj48Zm9udCBzdHlsZT0iZm9udC1z
aXplOjg1JTtmb250LWZhbWlseTphcmlhbCxzYW5zLXNlcmlmIj48ZGl2IHN0eWxlPSJwYWRkaW5n
LXRvcDowLjhlbTsiPjxpbWcgYWx0PSIiIGhlaWdodD0iMSIgd2lkdGg9IjEiIC8 PC9kaXY PGRp
diBjbGFzcz0ibGgiPjxhIGhyZWY9Imh0dHA6Ly9uZXdzLmdvb2dsZS5jb20vbmV3cy91cmw/c2E9
dCZhbXA7ZmQ9UiZhbXA7dXNnPUFGUWpDTkhjYjVsenJlWVJjcm91Tnl2WlljY1RWcE9vZFEmYW1w
O3VybD1odHRwOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL3N0b3J5L3JlZ2VuZXJvbi1maW5hbGx5
LWNhcHR1cmVzLWZkYS1vay1uZXctZXllLWRydWcvMjAxMS0xMS0yMSI PGI UmVnZW5lcm9uIGZp
bmFsbHkgY2FwdHVyZXMgYW4gRkRBIE9LIHdpdGggbmV3IGV5ZSBkcnVnPC9iPjwvYT48Zm9udCBz
aXplPSItMSI PGI PGZvbnQgY29sb3I9IiM2ZjZmNmYiPkZpZXJjZUJpb3RlY2g8L2ZvbnQ PC9i
PjwvZm9udD48Zm9udCBzaXplPSItMSI TGF0ZSBvbiBGcmlkYXkgUmVnZW5lcm9uIFBoYXJtYWNl
dXRpY2FscyBzY29yZWQgYSBiaWcgd2luIGFzIGl0IGFubm91bmNlZCB0aGF0IHRoZSBGREEgaGFz
IGFwcHJvdmVkIEV5bGVhIChhZmxpYmVyY2VwdCkgZm9yIHdldCwgYWdlLXJlbGF0ZWQgbWFjdWxh
ciBkZWdlbmVyYXRpb24uIEJ1dCBhZnRlciBwcmljaW5nIGFuIGluamVjdGlvbiBhdCBhIHNsaWdo
dCBkaXNjb3VudCB0byBSb2NoZSYjMzk7cyBMdWNlbnRpcy0tJDE4NTAgdG8gPGI Li4uPC9iPjwv
Zm9udD48Zm9udCBzaXplPSItMSI PGEgaHJlZj0iaHR0cDovL25ld3MuZ29vZ2xlLmNvbS9uZXdz
L3VybD9zYT10JmFtcDtmZD1SJmFtcDt1c2c9QUZRakNORlNiYzJGYjZGdnhld0VzMVdjcXN5enpY
cEtZZyZhbXA7dXJsPWh0dHA6Ly93d3cubnl0aW1lcy5jb20vMjAxMS8xMS8yMS9idXNpbmVzcy9l
eWxlYS1hLXZpc2lvbi1kcnVnLXdpbnMtbG9uZy1zb3VnaHQtYXBwcm92YWwuaHRtbCI U3VjY2Vz
cyBMb25nIGluIENvbWluZyBmb3IgRXlsZWEsIGEgVmlzaW9uIFRyZWF0bWVudDwvYT48L2ZvbnQ
PGZvbnQgc2l6ZT0iLTEiIGNvbG9yPSIjNmY2ZjZmIj48bm9icj5OZXcgWW9yayBUaW1lczwvbm9i
cj48L2ZvbnQ PC9kaXY PC9mb250Pjxmb250IHNpemU9Ii0xIj48YSBocmVmPSJodHRwOi8vbmV3
cy5nb29nbGUuY29tL25ld3MvdXJsP3NhPXQmYW1wO2ZkPVImYW1wO3VzZz1BRlFqQ05FTWJwQVFY
TU1iRGpLaFpfU090VmhRcDNPdWFBJmFtcDt1cmw9aHR0cDovL29ubGluZS53c2ouY29tL2FydGlj
bGUvQlQtQ08tMjAxMTExMTgtNzEzNDQ4Lmh0bWwiPkZEQSBBcHByb3ZlcyBSZWdlbmVyb24mIzM5
O3MgRXlsZWEgRm9yIFZpc2lvbi1Mb3NzIERpc2Vhc2U8L2E PC9mb250Pjxmb250IHNpemU9Ii0x
IiBjb2xvcj0iIzZmNmY2ZiI PG5vYnI V2FsbCBTdHJlZXQgSm91cm5hbDwvbm9icj48L2ZvbnQ
PGZvbnQgc2l6ZT0iLTEiPjxhIGhyZWY9Imh0dHA6Ly9uZXdzLmdvb2dsZS5jb20vbmV3cy91cmw/
c2E9dCZhbXA7ZmQ9UiZhbXA7dXNnPUFGUWpDTkU5Xzd3dkNQaUZTZC1rblN2eFh1bDNtTkh1RkEm
YW1wO3VybD1odHRwOi8vd3d3LmJ1c2luZXNzd2Vlay5jb20vbmV3cy8yMDExLTExLTE5L3JlZ2Vu
ZXJvbi13aW5zLWZkYS1hcHByb3ZhbC1mb3ItYmxpbmRuZXNzLWRydWctZXlsZWEuaHRtbCI UmVn
ZW5lcm9uIFdpbnMgRkRBIEFwcHJvdmFsIGZvciBCbGluZG5lc3MgRHJ1ZyBFeWxlYTwvYT48L2Zv
bnQ PGZvbnQgc2l6ZT0iLTEiIGNvbG9yPSIjNmY2ZjZmIj48bm9icj5CdXNpbmVzc1dlZWs8L25v
YnI PC9mb250Pjxmb250IHNpemU9Ii0xIiBjbGFzcz0icCI PGEgaHJlZj0iaHR0cDovL25ld3Mu
Z29vZ2xlLmNvbS9uZXdzL3VybD9zYT10JmFtcDtmZD1SJmFtcDt1c2c9QUZRakNORm5WME9LaW1D
bkJLeVBwc0o2LUZQUWxsMzA3USZhbXA7dXJsPWh0dHA6Ly93d3cuYmxvb21iZXJnLmNvbS9uZXdz
LzIwMTEtMTEtMTkvcmVnZW5lcm9uLXdpbnMtZmRhLWFwcHJvdmFsLWZvci1ibGluZG5lc3MtZHJ1
Zy1leWxlYS5odG1sIj48bm9icj5CbG9vbWJlcmc8L25vYnI PC9hPiZuYnNwOy08YSBocmVmPSJo
dHRwOi8vbmV3cy5nb29nbGUuY29tL25ld3MvdXJsP3NhPXQmYW1wO2ZkPVImYW1wO3VzZz1BRlFq
Q05IYldlVDVndTRCS05yQVFnZXBGTzZ2OFpoT1l3JmFtcDt1cmw9aHR0cDovL3d3dy5nb29nbGUu
Y29tL2hvc3RlZG5ld3MvYXAvYXJ0aWNsZS9BTGVxTTVqQW8zOF93YmM0aXVSLXpLTzgyaHMzUnBq
MTZRP2RvY0lkJTNENjllOGEyYWFjOWE3NGM1ZWJhNDkxY2U1OWM2NjA4NDAiPjxub2JyPlRoZSBB
c3NvY2lhdGVkIFByZXNzPC9ub2JyPjwvYT48bGluayByZWw9InN5bmRpY2F0aW9uLXNvdXJjZSIg
aHJlZj0id3d3LmFwLm9yZy82OWU4YTJhYWM5YTc0YzVlYmE0OTFjZTU5YzY2MDg0MCIgLz48L2Zv
bnQ PGZvbnQgY2xhc3M9InAiIHNpemU9Ii0xIj48YSBjbGFzcz0icCIgaHJlZj0iaHR0cDovL25l
d3MuZ29vZ2xlLmNvbS9uZXdzL21vcmU/bmVkPXVzJmFtcDt0b3BpYz1tJmFtcDtuY2w9ZGFyaG1m
Z18yVkxOWEFNMnlua2J1WEtRTUthek0iPjxub2JyPjxiPmFsbCAxNzggbmV3cyBhcnRpY2xlcyZu
YnNwOyZyYXF1bzs8L2I PC9ub2JyPjwvYT48L2ZvbnQ PC90ZD48L3RyPjwvdGFibGU PHA U291
cmNlOiA8YSBocmVmPSJodHRwOi8vbmV3cy5nb29nbGUuY29tL25ld3MvdXJsP3NhPXQmZmQ9UiZ1
c2c9QUZRakNOSGNiNWx6cmVZUmNyb3VOeXZaWWNjVFZwT29kUSZ1cmw9aHR0cDovL3d3dy5maWVy
Y2ViaW90ZWNoLmNvbS9zdG9yeS9yZWdlbmVyb24tZmluYWxseS1jYXB0dXJlcy1mZGEtb2stbmV3
LWV5ZS1kcnVnLzIwMTEtMTEtMjEiPmh0dHA6Ly9uZXdzLmdvb2dsZS5jb20vbmV3cy91cmw/c2E9
dCZmZD1SJnVzZz1BRlFqQ05IY2I1bHpyZVlSY3JvdU55dlpZY2NUVnBPb2RRJnVybD1odHRwOi8v
d3d3LmZpZXJjZWJpb3RlY2guY29tL3N0b3J5L3JlZ2VuZXJvbi1maW5hbGx5LWNhcHR1cmVzLWZk
YS1vay1uZXctZXllLWRydWcvMjAxMS0xMS0yMTwvYT48L3A PHA PGEgaHJlZj0iaHR0cDovL3d3
dy5zaXRlc3VjZXNzby5jb20vbGl2cm9zLXNvYnJlLW8tc3VjZXNzby1hanVkYW0tby1sZWl0b3It
Y29tLWJvbS1jb250ZXVkby1lbS1zdWEtcHJvY3VyYS1zb2JyZS1uZWdvY2lvcy1mb250ZXMtZGUt
cmVzcG9zdGEtZS1xdWFscXVlci1vcG9ydHVuaWRhZGUvIj5TaXRlPC9hPiA8YSBocmVmPSJodHRw
Oi8vd3d3LnNpdGVzdWNlc3NvLmNvbS9ub3RlYmJvay1wb2RlLXNlci1pbnN0YWxhZG8tbm8tZ29v
Z2xlLWNocm9tZS1zZW0tYXBsaWNhdGl2b3MtZS1jb21wbGVtZW50b3MtYXBlbmFzLWNvbS1jb25l
eGFvLW5hLWludGVybmV0LyI V2ViPC9hPiA8YSBocmVmPSJodHRwOi8vd3d3LnNpdGVzdWNlc3Nv
LmNvbS93b3JkcHJlc3Mtb3UtYmxvZ2dlci1wYXJhLWNyaWFyLXVtLWJsb2ctZGUtc3VjZXNzby1u
YS1pbnRlcm5ldC8iPkludGVybmV0PC9hPiA8YSBocmVmPSJodHRwOi8vd3d3LnNpdGVzdWNlc3Nv
LmNvbS9saXZyby1hcHJlc2VudGFkb3ItZXNjcml0b3Itam8tc29hcmVzLWZhei1ncmFuZGUtc3Vj
ZXNzby1jb21vLXJvbWFuY2UtaW50aXR1bGFkby1hcy1lc2dhbmFkYXMvIj5CbG9nPC9hPiA8L3A
PGhyIC8 IE9yaWduYWwgRnJvbTogPGEgaHJlZj0iaHR0cDovL2Jsb2dnZXItMTcubW9uZXlidXNp
bmVzc2Jsb2cuaW5mby8/cD0yNTMiIHRhcmdldD1fYmxhbms UmVnZW5lcm9uIGZpbmFsbHkgY2Fw
dHVyZXMgYW4gRkRBIE9LIHdpdGggbmV3IGV5ZSBkcnVnIC0gRmllcmNlQmlvdGVjaDwvYT4K